|
|
|
Volumn 271, Issue 2, 1994, Pages 683-694
|
|
Tandospirone and alprazolam: Comparison of behavioral effects and abuse liability in humans
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPRAZOLAM;
ANTIDEPRESSANT AGENT;
BARBITURIC ACID DERIVATIVE;
BENZODIAZEPINE;
CANNABIS;
CENTRAL STIMULANT AGENT;
MUSCLE RELAXANT AGENT;
NEUROLEPTIC AGENT;
OPIATE;
PLACEBO;
TANDOSPIRONE;
ADULT;
ARTICLE;
BEHAVIOR;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG ABUSE;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG IDENTIFICATION;
HUMAN;
MALE;
OBSERVER VARIATION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PSYCHOMOTOR PERFORMANCE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
ADULT;
ALPRAZOLAM;
ANTI-ANXIETY AGENTS;
BUSPIRONE;
CROSS-OVER STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
HUMANS;
MALE;
PIPERAZINES;
PSYCHOMOTOR PERFORMANCE;
PYRIMIDINES;
SEROTONIN AGONISTS;
SUBSTANCE-RELATED DISORDERS;
|
|
EID: 0027942788
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (53)
|
|
References (0)
|
